Cargando…
The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients—First European Data
INTRODUCTION AND OBJECTIVES: Novel biomarker research is vital for the progression of safe and thorough diagnostic medicine. There is now a need to improve the diagnosis of bladder cancer via a noninvasive urine test while balancing the risks of harm from investigational procedures, such as cystosco...
Autores principales: | Vasdev, Nikhil, Hampson, Alexander, Agarwal, Samita, Swamy, Rajiv, Chilvers, Michael, Hampson, Amy, Jahanfard, Sholeh, Kim, Nam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988772/ https://www.ncbi.nlm.nih.gov/pubmed/35474659 http://dx.doi.org/10.1002/bco2.50 |
Ejemplares similares
-
Technical caveats in salvage robot assisted radical prostatectomy
por: Tamhankar, Ashwin, et al.
Publicado: (2020) -
Palliative Radiation Therapy for Macroscopic Hematuria Caused by Urothelial Cancer
por: Zhang, Haiqin, et al.
Publicado: (2020) -
Blue light transurethral resection and biopsy of bladder cancer with hexaminolevulinate: Histopathological characteristics and recurrence rates in a single UK centre study
por: Chan, Kimberley, et al.
Publicado: (2023) -
Nefro-Uro /
Publicado: (2018) -
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
por: Bersanelli, Melissa, et al.
Publicado: (2021)